title: Drug development in IBD: from novel target identification to early clinical trials.
authors.affiliation: IBD Center, Department of Gastroenterology, Humanitas Research Hospital, Humanitas University, Milan, Italy.
authors.forename: Silvio
authors.initials: S
authors.lastname: Danese
authors.affiliation: Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland, Ohio, USA Department of Pathobiology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
authors.forename: Claudio
authors.initials: C
authors.lastname: Fiocchi
authors.affiliation: Gastroenterology Department, Hospital Clínic Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
authors.forename: Julián
authors.initials: J
authors.lastname: Panés
mesh_terms: D000818:Animals; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D023421:Models, Animal
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D005765:Gastrointestinal Agents
keywords: IBD; IBD CLINICAL; IBD MODELS